Oct. 22, 2025 — Qure has announced its latest (510) K clearance from the US Food and Drug Administration (FDA).
The ...
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
Oct. 22, 2025 — Qure has announced its latest (510) K clearance from the US Food and Drug Administration (FDA).
The ...
Oct. 22, 2025 — Nyra Medical, a leading innovator in structural heart therapies, has announced the initiation of its ...
Oct. 15, 2025 — Stereotaxis recently announced it has obtained CE Mark in Europe and submitted a 510(k) application to ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
Oct. 13, 2025 — Medtronic plc recently announced it has received U.S. Food and Drug Administration (FDA) labeling ...
Oct. 7, 2025 — Cagent Vascular has announced the commercial launch of the Serranator PTA Serration Balloon Catheter in 7 ...
Oct. 7, 2025 — Medtronic has announced the full distribution of the Neuroguard IEP System (Neuroguard) after a ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
Oct. 7, 2025 — Nobles Medical Technology II, a provider of cardiovascular closure solutions, has announced that the U.S ...
Oct. 2, 2025 — AorticLab recently announced the U.S. Food and Drug Administration (FDA) has approved its Investigational ...
Sept. 30, 2025 — Cleerly has announced that coverage policies from UnitedHealthcare and Cigna for Cleerly LABS advanced ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
Sept. 29, 2025 — AngioSafe has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ...
Sept. 25, 2025 — Kardigan has introduced the three late-stage clinical programs leading its robust pipeline, each ...
Sept. 24, 2025 — The Family Heart Foundation, a leading research and advocacy organization, has announced the online ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
Sept. 22, 2025 — Nicklaus Children's Heart Institute in Miami, Florida, is now offering bedside transcatheter patent ...
Sept. 22, 2025 — The latest findings on heart failure (HF) published by the Heart Failure Society of America (HFSA) reve ...
Sept. 18, 2025 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for treating cardiovascular and ...